Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy in the upper extremity. Treatments for CTS alternate from conservative strategies to surgical decompression of median nerve. Few studies have applied platelet-rich plasma (PRP) for treating idiopathic CTS, with acceptable success rates. Further studies are needed to reach concrete conclusion.
To study the effect of PRP injection in treatment of mild to moderate idiopathic CTS.
This is a randomized controlled trial in a cohort of Egyptian patients suffered from mild to moderate CTS. They were randomly divided into two groups. Group 1: patients received ultrasound guided PRP injection and group 2 patients received ultrasound guided corticosteroid injection. The outcome measures were assessed via Visual Analog Scale, the Boston Carpal Tunnel Syndrome Questionnaire, electrophysiological findings in sensory and motor functions of median nerve and morphological changes of median nerve detected by ultrasound.
This study included 150 patients suffered from mild to moderate idiopathic CTS 15 did not provide the written consent and 37 participants were excluded from the study based on the exclusion criteria leaving only 98 patients to participate in the study they were divided into two groups PRP Injection Group (PRP-inj-G) — this group included 49 patients (40 females and 9 males) steroid injection Group (St-inj-G) — included 49 patients (41 females and 8 males). At the beginning of study there was no significant difference between both groups in all parameters. (a) PRP injection had significantly improved the clinical manifestations, the electrodiagnostic examination (EDX) parameters of the median nerve (MN), and the median nerve cross sectional area (m-CSA) at 1 month and 3 months post-injection evaluation in comparison to baseline recordings; (b) local steroid injection had significantly improved the clinical manifestations, the EDX parameters of the MN, and the m-CSA at 1 month and 3 months post-injection evaluation in comparison to baseline recordings and (c) PRP injection was superior to the local steroid injection in the improvement of clinical manifestations as well as the MN motor conduction velocity along the wrist-elbow segment, the sensory latency (SL) and the MN sensory conduction, this superiority was observed in third month follow-up suggesting better outcomes in long-term follow-up.
Platelet-rich plasma could be effective treatment of mild to moderate idiopathic CTS and superior to corticosteroid in improving pain, function, and distal sensory latency of median nerve.
Clinical Trials.gov Identifier: NCT03863873
• PRP is effective treatment of mild to moderate CTS.
• PRP is superior to corticosteroids in improving pain and function in CTS.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Abductor pollicis brevis muscle
Boston carpal tunnel questionnaire
Boston carpal tunnel questionnaire functional status scale
Boston carpal tunnel questionnaire symptom severity scale
Carpal tunnel syndrome
Compound muscle action potential
Distal motor latency
Idiopathic carpal tunnel syndrome
Median cross sectional area
Platelet rich plasma
Randomized controlled trial
Sensory nerve action potential
Sensory nerve conduction velocity
Visual analog scale
Shiri R, Miranda H, Heliövaara M, Viikari-Juntura E (2009) Physical work load factors and carpal tunnel syndrome: a population-based study. Occup Environ Med 66(6):368–373
O'Connor D, Marshall S, Massy-Westropp N.(2003) Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome. Cochrane Database Syst Rev;(1):CD003219. Review
Katz JN, Keller RB, Simmons BP, Rogers WD, Bessette L, Fossel AH et al (1998) Maine carpal tunnel study: outcomes of operative and nonoperative therapy for carpal tunnel syndrome in a community-based cohort. J Hand Surg [Am] 23(4):697–710
Gerritsen AA, Korthals-de Bos IB, Laboyrie PM, de Vet HC, Scholten RJ, Bouter LM (2003) Splinting for carpal tunnel syndrome: prognostic indicators of success. J Neurol Neurosurg Psychiatry 74(9):1342–1344
Huisstede BM, Hoogvliet P, Randsdorp MS, Glerum S, van Middelkoop M, Koes BW (2010) Carpal tunnel syndrome. Part I: effectiveness of nonsurgical treatments--a systematic review. Arch Phys Med Rehabil 91(7):981–1004
Marshall S, Tardif G, Ashworth N(2007) "Local corticosteroid injection for carpal tunnel syndrome." Cochrane Database Syst Rev;(2):Cd001554
Sampson S, Gerhardt M, Mandelbaum B (2008) Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 1(3–4):165–174
Zheng C, Zhu Q, Liu X, Huang X, He C, etal JL (2016) Effect of platelet-rich plasma (PRP) concentration on proliferation, neurotrophic function and migration of Schwann cells in vitro. J Tissue Eng Regen Med 10(5):428–436
Uzun H, Bitik O, Uzun Ö, Ersoy US, Aktaş E (2016) Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome. J Plast Surg Hand Surg 51(5):301–305 1–5
You H, Simmons Z, Freivalds A, Kothari MJ, Naidu SH (1999) Relationships between clinical symptom severity scales and nerve conduction measures in CTS. Muscle Nerve 22:497–501
Werner RA, Andary M (2011) Electrodiagnostic evaluation of carpal tunnel syndrome. Muscle Nerve 44(4):597–607
Padua L, Lo Monaco M, Valente EM, Tonali PA (1996) A useful electrophysiologic parameter for diagnosis of carpal tunnel syndrome. Muscle Nerve 19(1):48–53
Wong SM, Griffith JF, Hui AC, Tang A, Wong KS (2002) Discriminatory sonographic criteria for the diagnosis of carpal tunnel syndrome. Arthritis Rheum 46(7):1914–1921
Miyamoto H, Halpern EJ, Kastlunger M, Gabl M, Arora R, Bellmann-Weiler R, Feuchtner GM, Jaschke WR, Klauser AS (2014) Carpal tunnel syndrome: diagnosis by means of median nerve elasticity--improved diagnostic accuracy of US with sonoelastography. Radiology. 270(2):481–486
Dhurat R, Sukesh M (2014) Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg 7(4):189–197
Wu YT, Ho TY, Chou YC, Ke MJ, Li TY, Huang GS, Chen LC (2017) Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Sci Rep 7(1):94
Lee JY, Park Y, Park KD, Lee JK, Lim OK (2014) Effectiveness of ultrasound-guided carpal tunnel injection using in-plane ulnar approach: a prospective, randomized, single-blinded study. Medicine (Baltimore) 93(29):e350
Jensen MP, Karoly P, Braver S (1986) The measurement of clinical pain intensity: a comparison of six methods. Pain. 27:117–126
Leite JC, Jerosch-Herold C, Song F (2006) A systematic review of the psychometric properties of the Boston Carpal Tunnel Questionnaire. BMC Musculoskelet Disord 7:78
Simovic D, Weinberg DH (1999) The median nerve terminal latency index in carpal tunnel syndrome: a clinical case selection study. Muscle Nerve 22:573–577
Macdonell RA, Schwartz MS, Swash M (1990) Carpal tunnel syndrome: which finger should be tested? An analysis of sensory conduction in digital branches of the median nerve. Muscle Nerve 13:601–606
Buchberger W, Judmaier W, Birbamer G, Lener M, Schmidauer C (1992) Carpal tunnel syndrome: diagnosis with high-resolution sonography. AJR Am J Roentgenol 159:793–798
Sánchez M, Anitua E, Delgado D, Prado R, Sánchez P, Fiz N et al (2017) Ultrasound-guided plasma rich in growth factors injections and scaffolds hasten motor nerve functional recovery in an ovine model of nerve crush injury. J Tissue Eng Regen Med 11(5):1619–1629
Piskin A, Kaplan S, Aktaş A, Ayyildiz M, Raimondo S, Aliç T (2009) Platelet gel does not improve peripheral nerve regeneration: an electrophysiological, stereological, and electron microscopic study. Microsurgery 29(2):144–153
Malahias MA, Johnson EO, Babis GC, Nikolaou VS (2015) Single injection of platelet-rich plasma as a novel treatment of carpal tunnel syndrome. Neural Regen Res 10(11):1856–1859
Atwaa ET, Esh AM, Abd El Al IT, Awad YM (2018) Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome: clinical and electrophysiological study. Egypt Rheumatolt 41(3):237–241
Uzun H, Bitik O, Uzun Ö, Ersoy US, Aktaş E (2017) Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome. J Plast Surg Hand Surg 51(5):301–305
Raeissadat SA, Karimzadeh A, Hashemi M, Bagherzadeh L (2018) Safety. Efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial. BMC Musculoskelet Disord 19(1):49
Agarwal V, Singh R, Sachdev A, Wiclaff, Shekhar S, Goel DA (2005) Prospective study of the long-term efficacy of local methyl prednisolone acetate injection in the management of mild carpal tunnel syndrome. Rheumatology (Oxford) 44(5):647–650
Peters-Veluthamaningal C, Winters JC, Groenier KH, Meyboom-de Jong B (2010) Randomised controlled trial of local corticosteroid injections for carpal tunnel syndrome in general practice. BMC Fam Pract 29(11):54
El-Badawy M (2015) Electrophysiological and clinical comparison of local steroid injection by means of proximal versus distal approach in patients with mild and moderate carpal tunnel syndrome. Egypt Rheumatol Rehabil 42(3):120–127
Soyupek F, Yesildag A, Kutluhan S, Askin A, Ozden A, etal UGA (2012) Determining the effectiveness of various treatment modalities in carpal tunnel syndrome by ultrasonography and comparing ultrasonographic findings with other outcomes. Rheumatol Int 32(10):3229–3234
Wu YT, Ke MJ, Chou YC, Chang CY, Lin CY, Li TY (2016) Effect of radial shock wave therapy for carpal tunnel syndrome: a prospective randomized, double-blind, placebo-controlled trial. J Orthop Res 34(6):977–984
Sánchez M, Garate A, Delgado D, Padilla S (2017) Platelet-rich plasma, an adjuvant biological therapy to assist peripheral nerve repair. Neural Regen Res 12(1):47–52
All authors wish to express deep appreciation and gratitude to professor Mohammad K. for his support in statistical analysis of this work and great appreciation to all cooperative patients participated in this study.
This study was totally funded by all authors. All authors are responsible for payment of publications fees. All authors declare that they did not receive any financial support.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Senna, M.K., Shaat, R.M. & Ali, A.A.A. Platelet-rich plasma in treatment of patients with idiopathic carpal tunnel syndrome. Clin Rheumatol 38, 3643–3654 (2019). https://doi.org/10.1007/s10067-019-04719-7
- Carpal tunnel syndrome
- Platelet rich plasma